23202730|t|Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes.
23202730|a|Deposition of amyloid beta protein (Abeta) to form neuritic plaques in the brain is the pathological hallmark of Alzheimer's disease (AD). Abeta is generated from sequential cleavages of the beta-amyloid precursor protein (APP) by the beta- and gamma-secretases, and beta-site APP-cleaving enzyme 1 (BACE1) is the beta-secretase essential for Abeta generation. Previous studies have indicated that glycogen synthase kinase 3 (GSK3) may play a role in APP processing by modulating gamma-secretase activity, thereby facilitating Abeta production. There are two highly conserved isoforms of GSK3: GSK3alpha and GSK3beta. We now report that specific inhibition of GSK3beta, but not GSK3alpha, reduced BACE1-mediated cleavage of APP and Abeta production by decreasing BACE1 gene transcription and expression. The regulation of BACE1 gene expression by GSK3beta was dependent on NF-kappaB signaling. Inhibition of GSK3 signaling markedly reduced Abeta deposition and neuritic plaque formation, and rescued memory deficits in the double transgenic AD model mice. These data provide evidence for regulation of BACE1 expression and AD pathogenesis by GSK3beta and that inhibition of GSK3 signaling can reduce Abeta neuropathology and alleviate memory deficits in AD model mice. Our study suggests that interventions that specifically target the beta-isoform of GSK3 may be a safe and effective approach for treating AD.
23202730	14	22	GSK3beta	Gene	56637
23202730	32	37	BACE1	Gene	23821
23202730	57	66	Alzheimer	Disease	MESH:D000544
23202730	126	131	Abeta	Gene	11820
23202730	141	157	neuritic plaques	Disease	MESH:D058225
23202730	203	222	Alzheimer's disease	Disease	MESH:D000544
23202730	224	226	AD	Disease	MESH:D000544
23202730	229	234	Abeta	Gene	11820
23202730	281	311	beta-amyloid precursor protein	Gene	11820
23202730	357	388	beta-site APP-cleaving enzyme 1	Gene	23821
23202730	390	395	BACE1	Gene	23821
23202730	433	438	Abeta	Gene	11820
23202730	488	514	glycogen synthase kinase 3	Gene	56637
23202730	516	520	GSK3	Gene	56637
23202730	617	622	Abeta	Gene	11820
23202730	678	682	GSK3	Gene	56637
23202730	684	693	GSK3alpha	Gene	606496
23202730	698	706	GSK3beta	Gene	56637
23202730	750	758	GSK3beta	Gene	56637
23202730	768	777	GSK3alpha	Gene	606496
23202730	787	792	BACE1	Gene	23821
23202730	822	827	Abeta	Gene	11820
23202730	853	858	BACE1	Gene	23821
23202730	912	917	BACE1	Gene	23821
23202730	937	945	GSK3beta	Gene	56637
23202730	963	972	NF-kappaB	Gene	18033
23202730	998	1002	GSK3	Gene	56637
23202730	1030	1035	Abeta	Gene	11820
23202730	1051	1059	neuritic	Disease	MESH:D058225
23202730	1090	1105	memory deficits	Disease	MESH:D008569
23202730	1131	1133	AD	Disease	MESH:D000544
23202730	1140	1144	mice	Species	10090
23202730	1192	1197	BACE1	Gene	23821
23202730	1213	1215	AD	Disease	MESH:D000544
23202730	1232	1240	GSK3beta	Gene	56637
23202730	1264	1268	GSK3	Gene	56637
23202730	1290	1295	Abeta	Gene	11820
23202730	1325	1340	memory deficits	Disease	MESH:D008569
23202730	1344	1346	AD	Disease	MESH:D000544
23202730	1353	1357	mice	Species	10090
23202730	1497	1499	AD	Disease	MESH:D000544
23202730	Association	MESH:D000544	56637
23202730	Positive_Correlation	11820	23821
23202730	Positive_Correlation	MESH:D058225	11820
23202730	Positive_Correlation	11820	56637
23202730	Association	MESH:D058225	56637
23202730	Association	18033	23821
23202730	Association	MESH:D000544	23821
23202730	Association	MESH:D000544	11820
23202730	Association	18033	56637
23202730	Association	MESH:D008569	56637
23202730	Positive_Correlation	23821	56637

